Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Fuji
Chinese Patent Office
Teva
Cerilliant
UBS
Cipla
Citi
McKinsey
Baxter

Generated: October 24, 2017

DrugPatentWatch Database Preview

EQUAGESIC Drug Profile

« Back to Dashboard

What is the patent landscape for Equagesic, and when can generic versions of Equagesic launch?

Equagesic is a drug marketed by Caraco and is included in one NDA.

The generic ingredient in EQUAGESIC is aspirin; meprobamate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.

Summary for Tradename: EQUAGESIC

US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EQUAGESIC at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Caraco
EQUAGESIC
aspirin; meprobamate
TABLET;ORAL011702-003Dec 29, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Harvard Business School
UBS
Farmers Insurance
US Department of Justice
US Army
McKinsey
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot